In a study of 349 newly diagnosed HNSCC patients and 295 cancer-free controls, ERCC3 and XPA expression levels were significantly reduced in HNSCC patients compared with controls (36). The gene discussed is ERCC3; the disease is head and neck squamous cell carcinoma.